H

HaTay Pharmaceutical JSC
VN:DHT

Watchlist Manager
HaTay Pharmaceutical JSC
VN:DHT
Watchlist
Price: 82 000 VND 2.37% Market Closed
Market Cap: 6.8T VND
Have any thoughts about
HaTay Pharmaceutical JSC?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

2T
+3%
Revenue
Growth Rates:
1 Year
-2%
3 Years
-7%
5 Years
-13%
7 Years
+41%
10 Years
+146%
72B
-4%
Operating Income
Growth Rates:
1 Year
-41%
3 Years
-23%
5 Years
-40%
7 Years
-16%
10 Years
+51%
68.3B
+2%
Net Income
Growth Rates:
1 Year
-35%
3 Years
-27%
5 Years
-38%
7 Years
-1%
10 Years
+86%

Earnings Waterfall
HaTay Pharmaceutical JSC

Revenue
2T VND
Cost of Revenue
-1.8T VND
Gross Profit
204.9B VND
Operating Expenses
-132.9B VND
Operating Income
72B VND
Other Expenses
-3.8B VND
Net Income
68.3B VND

Income Statement
HaTay Pharmaceutical JSC

Rotate your device to view
Income Statement
Currency: VND
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
821 572
N/A
820 054
0%
849 100
+4%
857 559
+1%
912 976
+6%
940 572
+3%
999 551
+6%
1 060 776
+6%
1 105 296
+4%
1 205 441
+9%
1 262 963
+5%
1 329 288
+5%
1 433 686
+8%
1 480 315
+3%
1 558 230
+5%
1 598 136
+3%
1 674 481
+5%
1 705 345
+2%
1 715 187
+1%
2 241 794
+31%
2 317 977
+3%
2 042 235
-12%
2 561 156
+25%
2 559 274
0%
2 455 633
-4%
2 006 475
-18%
2 386 412
+19%
2 309 156
-3%
2 161 848
-6%
1 609 364
-26%
2 017 080
+25%
1 582 890
-22%
1 749 385
+11%
1 837 395
+5%
1 928 912
+5%
2 072 196
+7%
2 059 424
-1%
1 999 304
-3%
2 005 751
+0%
1 952 464
-3%
2 018 122
+3%
Gross Profit
Cost of Revenue
(687 786)
(689 838)
(714 359)
(723 947)
(775 969)
(792 221)
(842 562)
(901 106)
(936 738)
(1 024 672)
(1 069 165)
(1 125 621)
(1 219 725)
(1 255 976)
(1 332 445)
(1 361 066)
(1 435 729)
(1 464 034)
(1 474 722)
(1 945 779)
(2 016 428)
(1 790 835)
(2 233 673)
(2 217 986)
(2 134 074)
(1 767 422)
(2 107 701)
(2 075 881)
(1 945 424)
(1 455 342)
(1 824 501)
(1 434 769)
(1 576 727)
(1 650 138)
(1 727 351)
(1 854 144)
(1 845 429)
(1 795 972)
(1 806 415)
(1 756 825)
(1 813 191)
Gross Profit
133 788
N/A
130 215
-3%
134 744
+3%
133 615
-1%
137 011
+3%
148 351
+8%
156 991
+6%
159 671
+2%
168 558
+6%
180 769
+7%
193 798
+7%
203 668
+5%
213 962
+5%
224 339
+5%
225 786
+1%
237 070
+5%
238 752
+1%
241 311
+1%
240 465
0%
296 015
+23%
301 549
+2%
251 401
-17%
327 483
+30%
341 288
+4%
321 559
-6%
239 053
-26%
278 712
+17%
233 275
-16%
216 424
-7%
154 022
-29%
192 580
+25%
148 121
-23%
172 659
+17%
187 256
+8%
201 561
+8%
218 052
+8%
213 995
-2%
203 331
-5%
199 336
-2%
195 639
-2%
204 931
+5%
Operating Income
Operating Expenses
(85 979)
(91 756)
(94 411)
(99 069)
(100 692)
(101 038)
(109 021)
(108 354)
(116 937)
(114 835)
(121 690)
(127 074)
(128 636)
(138 999)
(132 269)
(143 237)
(143 173)
(152 848)
(151 041)
(173 443)
(181 099)
(153 241)
(193 658)
(199 978)
(178 762)
(129 633)
(150 090)
(124 876)
(123 288)
(91 953)
(112 719)
(88 685)
(92 875)
(84 806)
(88 306)
(91 609)
(91 405)
(104 115)
(113 843)
(120 547)
(132 900)
Selling, General & Administrative
(85 979)
(91 756)
(94 411)
(99 070)
(100 693)
(96 943)
(109 021)
(108 353)
(116 936)
(114 835)
(121 689)
(127 073)
(128 635)
(135 800)
(132 270)
(143 238)
(143 174)
(149 469)
(151 041)
(173 443)
(181 099)
(150 256)
(193 658)
(199 978)
(178 762)
(125 769)
(150 090)
(124 876)
(123 288)
(88 558)
(112 878)
(88 844)
(93 034)
(81 655)
(88 306)
(91 609)
(91 405)
(104 115)
(113 843)
(120 547)
(132 900)
Depreciation & Amortization
0
0
0
0
0
(4 095)
0
0
0
0
0
0
0
(3 199)
0
0
0
(3 378)
0
0
0
(2 985)
0
0
0
(3 864)
0
0
0
(3 395)
0
0
0
(3 151)
0
0
0
0
0
0
0
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
159
159
159
0
0
0
0
0
0
0
0
Operating Income
47 808
N/A
38 459
-20%
40 331
+5%
34 544
-14%
36 317
+5%
47 313
+30%
47 969
+1%
51 317
+7%
51 621
+1%
65 934
+28%
72 107
+9%
76 593
+6%
85 325
+11%
85 340
+0%
93 516
+10%
93 832
+0%
95 578
+2%
88 464
-7%
89 424
+1%
122 572
+37%
120 450
-2%
98 159
-19%
133 825
+36%
141 311
+6%
142 797
+1%
109 420
-23%
128 621
+18%
108 399
-16%
93 136
-14%
62 070
-33%
79 861
+29%
59 436
-26%
79 783
+34%
102 450
+28%
113 255
+11%
126 443
+12%
122 590
-3%
99 216
-19%
85 492
-14%
75 092
-12%
72 031
-4%
Pre-Tax Income
Interest Income Expense
(768)
(2 949)
1 763
1 146
(1 672)
(48)
(464)
(465)
(674)
519
962
2 525
2 286
2 140
6 211
11 192
12 709
8 296
9 403
8 448
9 660
5 497
6 782
3 287
514
(684)
2 857
9 477
13 775
18 622
23 057
18 557
16 236
11 655
9 886
4 405
1 381
40
(801)
(1 240)
3 582
Non-Reccuring Items
0
0
0
0
0
(22)
0
0
0
0
0
0
0
(28)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(52)
0
0
0
Gain/Loss on Disposition of Assets
0
391
0
0
0
339
0
0
0
(387)
0
0
0
41
0
0
0
1 205
0
0
0
276
0
0
0
396
0
0
0
(77)
0
0
0
0
0
0
0
281
0
0
0
Total Other Income
7 088
3 945
4 956
5 113
5 818
3 636
5 173
3 771
4 472
5 469
4 765
7 331
9 768
8 260
8 737
7 650
7 286
7 923
10 493
13 662
12 982
8 728
12 264
12 488
14 195
11 403
16 247
16 217
14 296
8 898
11 062
8 498
8 176
9 118
9 670
9 733
10 515
10 858
11 438
12 729
13 065
Pre-Tax Income
54 128
N/A
39 845
-26%
47 050
+18%
40 803
-13%
40 463
-1%
51 218
+27%
52 678
+3%
54 623
+4%
55 419
+1%
71 535
+29%
77 833
+9%
86 447
+11%
97 377
+13%
95 753
-2%
108 462
+13%
112 674
+4%
115 573
+3%
105 888
-8%
109 321
+3%
144 682
+32%
143 092
-1%
112 660
-21%
152 871
+36%
157 086
+3%
157 507
+0%
120 536
-23%
147 726
+23%
134 092
-9%
121 207
-10%
89 513
-26%
113 980
+27%
86 491
-24%
104 195
+20%
123 224
+18%
132 811
+8%
140 580
+6%
134 486
-4%
110 344
-18%
96 129
-13%
86 581
-10%
88 677
+2%
Net Income
Tax Provision
(10 515)
(8 306)
(9 096)
(8 312)
(8 926)
(10 738)
(10 944)
(11 079)
(11 180)
(14 295)
(15 432)
(16 511)
(18 442)
(18 613)
(20 642)
(21 273)
(22 010)
(20 918)
(21 424)
(29 029)
(28 503)
(22 637)
(30 581)
(31 674)
(31 911)
(24 427)
(29 692)
(26 768)
(24 337)
(18 123)
(22 835)
(17 600)
(21 253)
(24 259)
(26 137)
(27 643)
(26 106)
(21 382)
(18 480)
(16 457)
(17 016)
Income from Continuing Operations
43 615
31 539
37 956
32 492
31 538
40 480
41 735
43 545
44 240
57 240
62 401
69 936
78 935
77 139
87 821
91 402
93 563
84 969
87 897
115 653
114 589
90 023
122 290
125 411
125 596
96 109
118 034
107 324
96 870
71 390
91 145
68 890
82 942
98 964
106 674
112 937
108 380
88 961
77 649
70 124
71 661
Income to Minority Interest
(3 121)
(5 241)
(2 213)
(3 111)
(2 966)
(3 692)
(3 711)
(3 643)
(3 972)
(3 442)
(4 150)
(5 137)
(6 273)
(5 002)
(5 717)
(6 330)
(5 133)
(3 889)
(4 561)
(4 200)
(4 314)
(3 790)
(4 680)
(5 164)
(4 794)
(4 061)
(5 047)
(4 082)
(3 784)
(3 444)
(4 503)
(3 920)
(3 804)
(3 753)
(3 766)
(3 572)
(3 922)
(3 906)
(4 343)
(3 284)
(3 381)
Net Income (Common)
36 769
N/A
26 298
-28%
32 017
+22%
29 381
-8%
28 572
-3%
34 354
+20%
35 589
+4%
37 467
+5%
37 832
+1%
50 032
+32%
54 485
+9%
61 033
+12%
68 897
+13%
72 137
+5%
82 104
+14%
85 072
+4%
88 430
+4%
81 080
-8%
83 336
+3%
111 453
+34%
110 275
-1%
86 233
-22%
117 610
+36%
120 248
+2%
120 801
+0%
92 047
-24%
112 987
+23%
103 243
-9%
93 085
-10%
67 946
-27%
86 642
+28%
64 970
-25%
79 139
+22%
95 211
+20%
102 908
+8%
109 365
+6%
104 458
-4%
85 056
-19%
73 306
-14%
66 840
-9%
68 280
+2%
EPS (Diluted)
1 750.9
N/A
1 268.73
-28%
1 524.61
+20%
1 399.09
-8%
1 360.57
-3%
1 657.42
+22%
1 694.71
+2%
1 784.14
+5%
1 801.52
+1%
2 413.81
+34%
2 594.52
+7%
968.77
-63%
1 680.41
+73%
4 387.89
+161%
5 864.57
+34%
3 038.28
-48%
4 265.96
+40%
4 532.62
+6%
4 020.54
-11%
5 275.66
+31%
5 219.9
-1%
4 242.39
-19%
5 786.03
+36%
5 691.97
-2%
5 718.17
+0%
1 244.88
-78%
5 348.28
+330%
3 909.39
-27%
3 524.78
-10%
926.02
-74%
3 306.35
+257%
2 441.59
-26%
1 070.29
-56%
1 287.67
+20%
1 391.75
+8%
1 479.08
+6%
1 412.73
-4%
1 681.99
+19%
890.26
-47%
811.77
-9%
923.44
+14%

See Also

Summary
DHT intrinsic value, competitors valuation, and company profile.
DCF Valuation
DHT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DHT stock valuation using valuation multiples.
Wall Street Estimates
DHT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DHT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.